Article Details
Retrieved on: 2022-08-30 14:03:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
DELIVER data at ESC22 puts AstraZeneca's SGLT2 inhibitor Farxiga back in contention with rival Jardiance in heart failure with preserved ejection ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here